EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design

Iker Malaina iD, Lorena Gonzalez-Melero iD, Luis Martínez, Aiala Salvador iD, Ana Sanchez-Diez, Aintzane Asumendi iD, Javier Margareto iD, Jose Carrasco-Pujante, Leire Legarreta iD, María Asunción García, Martín Blas Pérez-Pinilla, Rosa Izu iD und 5 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24109024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Iker Malaina und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basque Government, University of the Basque Country, Basque Center for Applied Mathematics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the last few years, the importance of neoantigens in the development of personalized antitumor vaccines has increased remarkably. In order to study whether bioinformatic tools are effective in detecting neoantigens that generate an immune response, DNA samples from patients with cutaneous melanoma in different stages were obtained, resulting in a total of 6048 potential neoantigens gathered. Thereafter, the immunological responses generated by some of those neoantigens ex vivo were tested, using a vaccine designed by a new optimization approach and encapsulated in nanoparticles. Our bioinformatic analysis indicated that no differences were found between the number of neoantigens and that of non-mutated sequences detected as potential binders by IEDB tools. However, those tools were able to highlight neoantigens over non-mutated peptides in HLA-II recognition (p-value 0.03). However, neither HLA-I binding affinity (p-value 0.08) nor Class I immunogenicity values (p-value 0.96) indicated significant differences for the latter parameters. Subsequently, the new vaccine, using aggregative functions and combinatorial optimization, was designed. The six best neoantigens were selected and formulated into two nanoparticles, with which the immune response ex vivo was evaluated, demonstrating a specific activation of the immune response. This study reinforces the use of bioinformatic tools in vaccine development, as their usefulness is proven both in silico and ex vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsCancer VaccinesNeoplasmsHumansAntigens, NeoplasmImmunityVaccine Development

Stichwörter der Autor:innen

bioinformaticsex vivohuman leucocytic antigenimmunogenicitynanoparticleneoantigenvaccine design

Substanzen

Antigens, NeoplasmCancer Vaccines

Autor:innen und Institutionen

  • Department of Mathematics, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
  • NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.
  • Bioaraba, NanoBioCel Research Group, 01009 Vitoria-Gasteiz, Spain.
  • Luis Martínez, Basque Center for Applied Mathematics BCAM, 48009 Bilbao, Spain.
  • Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). Institute of Health Carlos III, 28029 Madrid, Spain.
  • Department of Dermatology, Basurto University Hospital, 48013 Bilbao, Spain.

ORCID-Profile: Iker Malaina, Lorena Gonzalez-Melero, Aiala Salvador, Aintzane Asumendi, Javier Margareto, Leire Legarreta, Rosa Izu, Manoli Igartua, Santos Alonso, Rosa Maria Hernandez, María Dolores Boyano

Förderung

  • Basque Government
  • University of the Basque Country
  • Basque Center for Applied Mathematics
  • UPV/EHU
  • Basque Center of Applied Mathematics

Zitieren

APA

Malaina, I., Gonzalez-Melero, L., Martínez, L., Salvador, A., Sanchez-Diez, A., Asumendi, A., Margareto, J., Carrasco-Pujante, J., Legarreta, L., García, M. A., Pérez-Pinilla, M. B., Izu, R., Martínez de la Fuente, I., Igartua, M., Alonso, S., Hernandez, R. M., & Boyano, M. D. (2023). Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24109024

Vancouver

Malaina I, Gonzalez-Melero L, Martínez L, Salvador A, Sanchez-Diez A, Asumendi A, et al. Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24109024

BibTeX
@article{Malaina2023,
  author = {Malaina, Iker and Gonzalez-Melero, Lorena and Martínez, Luis and Salvador, Aiala and Sanchez-Diez, Ana and Asumendi, Aintzane and Margareto, Javier and Carrasco-Pujante, Jose and Legarreta, Leire and García, María Asunción and Pérez-Pinilla, Martín Blas and Izu, Rosa and Martínez de la Fuente, Ildefonso and Igartua, Manoli and Alonso, Santos and Hernandez, Rosa Maria and Boyano, María Dolores},
  title = {Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24109024}
}
Kostenlos starten →